Publications by Lina Prasmickaite

56 publications found

  1. Valsalakumari R, Pandya AD, Prasmickaite L, Kvalvaag A, Myrann AG, Åslund AKO, Kjos MS, Fontecha-Cuenca C, Haroon HB, Ribeiro ARS, Horejs-Hoeck J, Moghimi SM, Mørch Ý, Skotland T, Sandvig K, Mælandsmo GM, Iversen TG (2024)
    Preclinical Efficacy of Cabazitaxel Loaded Poly(2-alkyl cyanoacrylate) Nanoparticle Variants
    Int J Nanomedicine, 19, 3009-3029
    DOI 10.2147/IJN.S450283, PubMed 38562610
  2. Ghannoum S, Fantini D, Zahoor M, Reiterer V, Phuyal S, Leoncio Netto W, Sørensen Ø, Iyer A, Sengupta D, Prasmickaite L, Mælandsmo GM, Köhn-Luque A, Farhan H (2023)
    A combined experimental-computational approach uncovers a role for the Golgi matrix protein Giantin in breast cancer progression
    PLoS Comput Biol, 19 (4), e1010995
    DOI 10.1371/journal.pcbi.1010995, PubMed 37068117
  3. Pettersen S, Øy GF, Egeland EV, Juell S, Engebråten O, Mælandsmo GM, Prasmickaite L (2023)
    Breast cancer patient-derived explant cultures recapitulate in vivo drug responses
    Front Oncol, 13, 1040665
    DOI 10.3389/fonc.2023.1040665, PubMed 36910663
  4. Nyakas M, Fleten KG, Haugen MH, Engedal N, Sveen C, Farstad IN, Flørenes VA, Prasmickaite L, Mælandsmo GM, Seip K (2022)
    AXL inhibition improves BRAF-targeted treatment in melanoma
    Sci Rep, 12 (1), 5076
    DOI 10.1038/s41598-022-09078-z, PubMed 35332208
  5. Barkovskaya A, Goodwin CM, Seip K, Hilmarsdottir B, Pettersen S, Stalnecker C, Engebraaten O, Briem E, Der CJ, Moestue SA, Gudjonsson T, Maelandsmo GM, Prasmickaite L (2021)
    Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen
    Mol Oncol, 15 (8), 2026-2045
    DOI 10.1002/1878-0261.12951, PubMed 33759347
  6. Barkovskaya A, Seip K, Prasmickaite L, Mills IG, Moestue SA, Itkonen HM (2020)
    Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells
    Sci Rep, 10 (1), 16992
    DOI 10.1038/s41598-020-74083-z, PubMed 33046784
  7. Seip K, Jørgensen K, Haselager MV, Albrecht M, Haugen MH, Egeland EV, Lucarelli P, Engebraaten O, Sauter T, Mælandsmo GM, Prasmickaite L (2018)
    Stroma-induced phenotypic plasticity offers phenotype-specific targeting to improve melanoma treatment
    Cancer Lett, 439, 1-13
    DOI 10.1016/j.canlet.2018.09.023, PubMed 30240588
  8. Prasmickaite L, Tenstad EM, Pettersen S, Jabeen S, Egeland EV, Nord S, Pandya A, Haugen MH, Kristensen VN, Børresen-Dale AL, Oslo Breast Cancer Research Consortium (OSBREAC), Engebråten O, Maelandsmo GM (2018)
    Basal-like breast cancer engages tumor-supportive macrophages via secreted factors induced by extracellular S100A4
    Mol Oncol, 12 (9), 1540-1558
    DOI 10.1002/1878-0261.12319, PubMed 29741811
  9. Eng MS, Kaur J, Prasmickaite L, Engesæter BØ, Weyergang A, Skarpen E, Berg K, Rosenblum MG, Mælandsmo GM, Høgset A, Ferrone S, Selbo PK (2018)
    Enhanced targeting of triple-negative breast carcinoma and malignant melanoma by photochemical internalization of CSPG4-targeting immunotoxins
    Photochem Photobiol Sci, 17 (5), 539-551
    DOI 10.1039/C7PP00358G, PubMed 29565434
  10. Fleten KG, Flørenes VA, Prasmickaite L, Hill O, Sykora J, Mælandsmo GM, Engesæter B (2016)
    hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma
    Cell Death Discov, 2, 16081
    DOI 10.1038/cddiscovery.2016.81, PubMed 28028438
  11. Seip K, Fleten KG, Barkovskaya A, Nygaard V, Haugen MH, Engesæter BØ, Mælandsmo GM, Prasmickaite L (2016)
    Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors
    Oncotarget, 7 (15), 19997-20015
    DOI 10.18632/oncotarget.7671, PubMed 26918352
  12. Evensen L, Johansen PL, Koster G, Zhu K, Herfindal L, Speth M, Fenaroli F, Hildahl J, Bagherifam S, Tulotta C, Prasmickaite L, Mælandsmo GM, Snaar-Jagalska E, Griffiths G (2016)
    Zebrafish as a model system for characterization of nanoparticles against cancer
    Nanoscale, 8 (2), 862-77
    DOI 10.1039/c5nr07289a, PubMed 26648525
  13. Bettum IJ, Gorad SS, Barkovskaya A, Pettersen S, Moestue SA, Vasiliauskaite K, Tenstad E, Øyjord T, Risa Ø, Nygaard V, Mælandsmo GM, Prasmickaite L (2015)
    Metabolic reprogramming supports the invasive phenotype in malignant melanoma
    Cancer Lett, 366 (1), 71-83
    DOI 10.1016/j.canlet.2015.06.006, PubMed 26095603
  14. Prasmickaite L, Berge G, Bettum IJ, Aamdal S, Hansson J, Bastholt L, Øijordsbakken M, Boye K, Mælandsmo GM (2015)
    Evaluation of serum osteopontin level and gene polymorphism as biomarkers: analyses from the Nordic Adjuvant Interferon alpha Melanoma trial
    Cancer Immunol Immunother, 64 (6), 769-76
    DOI 10.1007/s00262-015-1686-4, PubMed 25832001
  15. Nygaard V, Prasmickaite L, Vasiliauskaite K, Clancy T, Hovig E (2014)
    Melanoma brain colonization involves the emergence of a brain-adaptive phenotype
    Oncoscience, 1 (1), 82-94
    DOI 10.18632/oncoscience.11, PubMed 25593989
  16. Skrbo N, Hjortland GO, Kristian A, Holm R, Nord S, Prasmickaite L, Engebraaten O, Mælandsmo GM, Sørlie T, Andersen K (2014)
    Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft
    PLoS One, 9 (11), e113278
    DOI 10.1371/journal.pone.0113278, PubMed 25419568
  17. Bettum IJ, Vasiliauskaite K, Nygaard V, Clancy T, Pettersen SJ, Tenstad E, Mælandsmo GM, Prasmickaite L (2013)
    Metastasis-associated protein S100A4 induces a network of inflammatory cytokines that activate stromal cells to acquire pro-tumorigenic properties
    Cancer Lett, 344 (1), 28-39
    DOI 10.1016/j.canlet.2013.10.036, PubMed 24215866
  18. Bøe S, Prasmickaite L, Engesæter B, Hovig E (2011)
    Light-directed delivery of nucleic acids
    Methods Mol Biol, 764, 107-21
    DOI 10.1007/978-1-61779-188-8_7, PubMed 21748636
  19. Berg K, Berstad M, Prasmickaite L, Weyergang A, Selbo PK, Hedfors I, Høgset A (2010)
    Photochemical internalization: a new tool for gene and oligonucleotide delivery
    Top Curr Chem, 296, 251-81
    DOI 10.1007/128_2010_63, PubMed 21504105
  20. Berg K, Weyergang A, Prasmickaite L, Bonsted A, Høgset A, Strand MT, Wagner E, Selbo PK (2010)
    Photochemical internalization (PCI): a technology for drug delivery
    Methods Mol Biol, 635, 133-45
    DOI 10.1007/978-1-60761-697-9_10, PubMed 20552345
  21. Prasmickaite L, Engesaeter BØ, Skrbo N, Hellenes T, Kristian A, Oliver NK, Suo Z, Maelandsmo GM (2010)
    Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma
    PLoS One, 5 (5), e10731
    DOI 10.1371/journal.pone.0010731, PubMed 20505780
  22. Prasmickaite L, Skrbo N, Høifødt HK, Suo Z, Engebråten O, Gullestad HP, Aamdal S, Fodstad Ø, Maelandsmo GM (2010)
    Human malignant melanoma harbours a large fraction of highly clonogenic cells that do not express markers associated with cancer stem cells
    Pigment Cell Melanoma Res, 23 (3), 449-51
    DOI 10.1111/j.1755-148X.2010.00690.x, PubMed 20236249
  23. Cedervall J, Jamil S, Prasmickaite L, Cheng Y, Eskandarpour M, Hansson J, Maelandsmo GM, Ringborg U, Gulyas M, Zhen HS, Kanter L, Ahrlund-Richter L (2009)
    Species-specific in vivo engraftment of the human BL melanoma cell line results in an invasive dedifferentiated phenotype not present in xenografts
    Cancer Res, 69 (9), 3746-54
    DOI 10.1158/0008-5472.CAN-08-3746, PubMed 19383913
  24. Bonsted A, Wagner E, Prasmickaite L, Høgset A, Berg K (2008)
    Photochemical enhancement of DNA delivery by EGF receptor targeted polyplexes
    Methods Mol Biol, 434, 171-81
    DOI 10.1007/978-1-60327-248-3_11, PubMed 18470645
  25. Rappa G, Mercapide J, Anzanello F, Prasmickaite L, Xi Y, Ju J, Fodstad O, Lorico A (2008)
    Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets
    Exp Cell Res, 314 (10), 2110-22
    DOI 10.1016/j.yexcr.2008.03.008, PubMed 18423605
  26. Berg K, Folini M, Prasmickaite L, Selbo PK, Bonsted A, Engesaeter BØ, Zaffaroni N, Weyergang A, Dietze A, Maelandsmo GM, Wagner E, Norum OJ, Høgset A (2007)
    Photochemical internalization: a new tool for drug delivery
    Curr Pharm Biotechnol, 8 (6), 362-72
    DOI 10.2174/138920107783018354, PubMed 18289045
  27. Lillehammer T, Engesaeter BO, Prasmickaite L, Maelandsmo GM, Fodstad O, Engebraaten O (2007)
    Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines
    J Gene Med, 9 (6), 440-51
    DOI 10.1002/jgm.1036, PubMed 17410615
  28. Prasmickaite L, Cekaite L, Hellum M, Hovig E, Høgset A, Berg K (2006)
    Transcriptome changes in a colon adenocarcinoma cell line in response to photochemical treatment as used in photochemical internalisation (PCI)
    FEBS Lett, 580 (24), 5739-46
    DOI 10.1016/j.febslet.2006.09.028, PubMed 17007842
  29. Dietze A, Selbo PK, Prasmickaite L, Weyergang A, Bonsted A, Engesaeter B, Hogset A, Berg K (2006)
    Photochemical internalization (PCI): a new modality for light activation of endocytosed therapeuticals
    J Environ Pathol Toxicol Oncol, 25 (1-2), 521-36
    DOI 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.330, PubMed 16566739
  30. Prasmickaite L, Hellum M, Kaalhus O, Høgset A, Wagner E, Berg K (2006)
    Photochemical internalization of transgenes controlled by the heat-shock protein 70 promoter
    Photochem Photobiol, 82 (3), 809-16
    DOI 10.1562/2005-11-07-RA-731, PubMed 16420102
  31. Bonsted A, Engesaeter BØ, Høgset A, Maelandsmo GM, Prasmickaite L, D'Oliveira C, Hennink WE, van Steenis JH, Berg K (2006)
    Photochemically enhanced transduction of polymer-complexed adenovirus targeted to the epidermal growth factor receptor
    J Gene Med, 8 (3), 286-97
    DOI 10.1002/jgm.853, PubMed 16342300
  32. Berg K, Selbo PK, Weyergang A, Dietze A, Prasmickaite L, Bonsted A, Engesaeter BØ, Angell-Petersen E, Warloe T, Frandsen N, Høgset A (2005)
    Porphyrin-related photosensitizers for cancer imaging and therapeutic applications
    J Microsc, 218 (Pt 2), 133-47
    DOI 10.1111/j.1365-2818.2005.01471.x, PubMed 15857375
  33. Kloeckner J, Prasmickaite L, Høgset A, Berg K, Wagner E (2004)
    Photochemically enhanced gene delivery of EGF receptor-targeted DNA polyplexes
    J Drug Target, 12 (4), 205-13
    DOI 10.1080/10611860410001723090, PubMed 15506169
  34. Prasmickaite L, Høgset A, Engesaeter B BØ, Bonsted A, Berg K (2004)
    Light-directed gene delivery by photochemical internalisation
    Expert Opin Biol Ther, 4 (9), 1403-12
    DOI 10.1517/14712598.4.9.1403, PubMed 15335308
  35. Berg K, Selbo PK, Prasmickaite L, Høgset A (2004)
    Photochemical drug and gene delivery
    Curr Opin Mol Ther, 6 (3), 279-87
    PubMed 15264430
  36. Prasmickaite L, Høgset A, Olsen VM, Kaalhus O, Mikalsen SO, Berg K (2004)
    Photochemically enhanced gene transfection increases the cytotoxicity of the herpes simplex virus thymidine kinase gene combined with ganciclovir
    Cancer Gene Ther, 11 (7), 514-23
    DOI 10.1038/sj.cgt.7700720, PubMed 15118758
  37. Bonsted A, Engesaeter BØ, Høgset A, Maelandsmo GM, Prasmickaite L, Kaalhus O, Berg K (2004)
    Transgene expression is increased by photochemically mediated transduction of polycation-complexed adenoviruses
    Gene Ther, 11 (2), 152-60
    DOI 10.1038/sj.gt.3302166, PubMed 14712299
  38. Høgset A, Prasmickaite L, Selbo PK, Hellum M, Engesaeter BØ, Bonsted A, Berg K (2004)
    Photochemical internalisation in drug and gene delivery
    Adv Drug Deliv Rev, 56 (1), 95-115
    DOI 10.1016/j.addr.2003.08.016, PubMed 14706447
  39. Berg K, Prasmickaite L, Selbo PK, Hellum M, Bonsted A, Høgset A (2003)
    Photochemical internalization (PCI)--a novel technology for release of macromolecules from endocytic vesicles
    Oftalmologia, 56 (1), 67-71
    PubMed 12886687
  40. Folini M, Berg K, Millo E, Villa R, Prasmickaite L, Daidone MG, Benatti U, Zaffaroni N (2003)
    Photochemical internalization of a peptide nucleic acid targeting the catalytic subunit of human telomerase
    Cancer Res, 63 (13), 3490-4
    PubMed 12839932
  41. Høgset A, Prasmickaite L, Hellum M, Engesaeter BO, Olsen VM, Tjelle TE, Wheeler CJ, Berg K (2002)
    Photochemical transfection: a technology for efficient light-directed gene delivery
    Somat Cell Mol Genet, 27 (1-6), 97-113
    DOI 10.1023/a:1022979806314, PubMed 12774944
  42. Hellum M, Høgset A, Engesaeter BO, Prasmickaite L, Stokke T, Wheeler C, Berg K (2003)
    Photochemically enhanced gene delivery with cationic lipid formulations
    Photochem Photobiol Sci, 2 (4), 407-11
    DOI 10.1039/b211880g, PubMed 12760539
  43. Høgset A, Prasmickaite L, Engesaeter BO, Hellum M, Selbo PK, Olsen VM, Maelandsmo GM, Berg K (2003)
    Light directed gene transfer by photochemical internalisation
    Curr Gene Ther, 3 (2), 89-112
    DOI 10.2174/1566523034578438, PubMed 12653404
  44. Selbo PK, Høgset A, Prasmickaite L, Berg K (2002)
    Photochemical internalisation: a novel drug delivery system
    Tumour Biol, 23 (2), 103-12
    DOI 10.1159/000059713, PubMed 12065848
  45. Prasmickaite L, Høgset A, Berg K (2002)
    The role of the cell cycle on the efficiency of photochemical gene transfection
    Biochim Biophys Acta, 1570 (3), 210-8
    DOI 10.1016/s0304-4165(02)00202-7, PubMed 12020812
  46. Prasmickaite L, Høgset A, Berg K (2002)
    Photochemical transfection. Light-induced, site-directed gene delivery
    Methods Mol Med, 69, 123-35
    DOI 10.1385/1-59259-141-8:123, PubMed 11987772
  47. Høgset A, Engesaeter BO, Prasmickaite L, Berg K, Fodstad O, Maelandsmo GM (2002)
    Light-induced adenovirus gene transfer, an efficient and specific gene delivery technology for cancer gene therapy
    Cancer Gene Ther, 9 (4), 365-71
    DOI 10.1038/sj.cgt.7700447, PubMed 11960287
  48. Prasmickaite L, Høgset A, Selbo PK, Engesaeter BØ, Hellum M, Berg K (2002)
    Photochemical disruption of endocytic vesicles before delivery of drugs: a new strategy for cancer therapy
    Br J Cancer, 86 (4), 652-7
    DOI 10.1038/sj.bjc.6600138, PubMed 11870551
  49. Prasmickaite L, Høgset A, Berg K (2001)
    Evaluation of different photosensitizers for use in photochemical gene transfection
    Photochem Photobiol, 73 (4), 388-95
    DOI 10.1562/0031-8655(2001)073<0388:eodpfu>2.0.co;2, PubMed 11332034
  50. Prasmickaite L, Høgset A, Tjelle TE, Olsen VM, Berg K (2000)
    Role of endosomes in gene transfection mediated by photochemical internalisation (PCI)
    J Gene Med, 2 (6), 477-88
    DOI 10.1002/1521-2254(200011/12)2:6<477::AID-JGM137>3.0.CO;2-B, PubMed 11199268
  51. Høgset A, Prasmickaite L, Tjelle TE, Berg K (2000)
    Photochemical transfection: a new technology for light-induced, site-directed gene delivery
    Hum Gene Ther, 11 (6), 869-80
    DOI 10.1089/10430340050015482, PubMed 10779164
  52. Berg K, Selbo PK, Prasmickaite L, Tjelle TE, Sandvig K, Moan J, Gaudernack G, Fodstad O, Kjølsrud S, Anholt H, Rodal GH, Rodal SK, Høgset A (1999)
    Photochemical internalization: a novel technology for delivery of macromolecules into cytosol
    Cancer Res, 59 (6), 1180-3
    PubMed 10096543
  53. Prasmickaite L, Hogset A, Maelandsmo G, Berg K, Goodchild J, Perkins T, Fodstad O, Hovig E (1998)
    Intracellular metabolism of a 2'-O-methyl-stabilized ribozyme after uptake by DOTAP transfection or asfree ribozyme. A study by capillary electrophoresis
    Nucleic Acids Res, 26 (18), 4241-8
    DOI 10.1093/nar/26.18.4241, PubMed 9722645
  54. Kirveliene V, Prasmickaite L, Kadziauskas J, Bonnett R, Djelal BD, Juodka B (1997)
    Post-exposure processes in Temoporfin-photosensitized cells in vitro: reliance on energy metabolism
    J Photochem Photobiol B, 41 (1-2), 173-80
    DOI 10.1016/s1011-1344(97)00107-3, PubMed 9440323
  55. Hellum M, Hogset A, Engesaeter BO, Prasmickaite L, Stokke T, Wheeler C, Berg K (2003)
    Photochemically enhanced gene delivery with cationic lipid formulations
    Photochem. Photobiol. Sci., 2 (4), 407-411
    DOI 10.1039/b211880g
  56. Berg K, Høgset A, Prasmickaite L, Weyergang A, Bonsted A, Dietze A, Lou PJ, Bown S, Norum OJ, Møllergard HM, Selbo PK (2006)
    Photochemical internalization (PCI): A novel technology for activation of endocytosed therapeutic agents.
    Med Laser Appl, 21, 239-251
    DOI 10.1016/j.mla.2006.08.004, PublikaID 73

 
Page visits: 710